Systemic lupus erythematosus (SLE), the embodiment of a multi-organ autoimmune disease, results from hyperactivation of host-defence pathways and immune recognition of the most fundamental building blocks of life. In 2018, key advances have placed intestinal immunity and dysregulated expansions of candidate pathobionts at the forefront of SLE pathogenesis.
Key advances
-
Pathobiont translocation from the small intestine to the liver in lupus-prone mice, and in a subset of patients with systemic lupus erythematosus (SLE), might drive the expression of interferon-related genes and autoantibody production2.
-
Immune priming to primitive bacterial commensal orthologues of the ribonucleoprotein Ro60 results in both physiological autoimmunity and disease-associated autoimmunity in predisposed individuals4.
-
Patients with SLE had a restricted gut microbiota diversity of similar composition to patients with Sjögren syndrome; by contrast, the oral microbiota composition of these two patient groups differed substantially7.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impact of diet and host genetics on the murine intestinal mycobiome
Nature Communications Open Access 14 February 2023
-
Fecal microbiota changes in NZB/W F1 mice after induction of lupus disease
Scientific Reports Open Access 25 November 2021
-
Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice
Arthritis Research & Therapy Open Access 14 September 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Bengtsson, A. A. & Ronnblom, L. Role of interferons in SLE. Best Pract. Res. Clin. Rheumatol. 31, 415–428 (2017).
Manfredo Vieira, S. et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359, 1156–1161 (2018).
Chen, Y. et al. Microbial symbionts regulate the primary Ig repertoire. J. Exp. Med. 215, 1397–1415 (2018).
Greiling, T. M. et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci. Transl Med. 10, eaan2306 (2018).
Rosenbaum, J. T. & Silverman, G. J. The microbiome and systemic lupus erythematosus. N. Engl. J. Med. 378, 2236–2237 (2018).
Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).
van der Meulen, T. A. et al. Shared gut, but distinct oral microbiota composition in primary Sjogren’s syndrome and systemic lupus erythematosus. J. Autoimmun. https://doi.org/10.1016/j.jaut.2018.10.009 (2018).
Silverman, G. J. et al. Lupus nephritis is linked to immunity to an intestinal commensal lachnospiraceae species [abstract]. Arthritis Rheumatol. 69 (Suppl. 10), 1786 (2018).
Silverman, G. J. et al. Identification of a gut pathobiont immunostimulatory lipoglycan antigen linked to lupus nephritis [abstract]. Arthritis Rheumatol. 70 (Suppl. 10), 104 (2018).
Taroncher-Oldenburg, G. et al. Translating microbiome futures. Nat. Biotechnol. 36, 1037–1042 (2018).
Acknowledgements
The author declares that he is supported by grants from the NIH and the Judith and Stewart Colton Autoimmunity Center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Silverman, G.J. The microbiome in SLE pathogenesis. Nat Rev Rheumatol 15, 72–74 (2019). https://doi.org/10.1038/s41584-018-0152-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-018-0152-z
This article is cited by
-
Impact of diet and host genetics on the murine intestinal mycobiome
Nature Communications (2023)
-
Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice
Arthritis Research & Therapy (2021)
-
Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
Nature Reviews Rheumatology (2021)
-
Fecal microbiota changes in NZB/W F1 mice after induction of lupus disease
Scientific Reports (2021)
-
Lupus nephritis
Nature Reviews Disease Primers (2020)